鼻咽癌SIB-IMRT治疗前生存与晚期毒性预后因素
该单中心回顾性研究纳入219例接受SIB-IMRT的非远处转移鼻咽癌患者,分析治疗前社会人口学、TNM分期、GTV、EBV-DNA及血液炎症标志物与生存和晚期毒性的关系。多因素分析显示N2-3分期是四项生存结局的唯一显著负性预后因素,GTV较大与较差LRRFS及更高放射性神经病变发生率相关。
要点
- N2-3分期是全部四项生存结局的唯一显著负性预后因素。
- 单核细胞百分比升高与较差FFS显著相关,淋巴细胞/单核细胞比值降低与较差OS显著相关。
- GTV较大预测较差LRRFS,且T3-4或GTV较高与放射性神经病变发生率更高相关。
核心结论
- 校正生物标志物后,N分期仍是SIB-IMRT治疗鼻咽癌最显著的生存预测因素。
- GTV不仅影响局部区域控制,还与放射性神经病变相关。
研究设计与样本
- 单中心连续纳入219例非远处转移鼻咽癌患者,均接受SIB-IMRT。
- 分析治疗前社会人口学变量、TNM分期、GTV、EBV-DNA及血液炎症标志物。
- 采用Cox模型筛选晚期毒性和四项生存结局的预后因素。
主要发现
- 5年LRRFS、DMFS、FFS和OS率分别为87.9%、89.4%、79.4%和81.3%。
- EBV-DNA、部分血液炎症标志物、GTV与N分类之间存在显著相互关联。
- 多因素分析显示N2-3对比N0-1是全部四项生存结局的唯一显著负性预后因素。
- 单核细胞百分比升高与较差FFS显著相关,淋巴细胞/单核细胞比值降低与较差OS显著相关。
- GTV较大预测较差LRRFS;T3-4(HR: 3.5,95%CI: 1.0-12.1,p=0.048)或GTV较高(HR: 1.006,95%CI: 1.001-1.011,p=0.027)与放射性神经病变发生率更高相关。
临床怎么用
- 治疗前应重点关注N分期,N2-3患者预后较差。
- GTV较大者需关注局部区域控制及放射性神经病变风险。
- 单核细胞百分比升高或淋巴细胞/单核细胞比值降低可能提示FFS或OS较差。
局限性
- 单中心回顾性研究,样本量219例,结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To scrutinize the pretreatment prognosticators on survival and late toxicities in a homogenous cohort of nasopharyngeal carcinoma (NPC) patients treated by simultaneous integrated boost intensity-modulated radiation therapy (SIB-IMRT). METHODS: A total of 219 non-distant metastatic NPC patients consecutively treated by SIB-IMRT at a single institute were collected. The pretreatment factors including the socio-demographic variables, TNM stages, gross tumor volume (GTV), Epstein-Barr virus (EBV)-DNA, and hematologic inflammatory markers were analyzed. Cox model was used to screen the prognostic factors of late toxicities and four survival outcomes including locoregional relapse-free survival (LRRFS), distant metastasis-free survival (DMFS), failure-free survival (FFS), and overall survival (OS). RESULTS: Statistically significant inter-correlations were observed between the values of EBV-DNA, some hematologic inflammatory markers, GTV, and N classification. The 5-year LRRFS, DMFS, FFS, and OS rates were 87.9%, 89.4%, 79.4%, and 81.3%, respectively. Multivariate analysis revealed that advanced N classification (N2-3 vs. N0-1) remained the only significant negative prognosticator for all the four survival outcomes. An increased monocyte percentage and a decreased lymphocyte-to-monocyte ratio were significantly associated with poorer FFS and OS, respectively. Larger GTV was observed to be predictive of poorer LRRFS. Patients with T3-4 (HR: 3.5, 95% CI: 1.0-12.1, p = 0.048) or higher GTV (HR: 1.006, 95% CI: 1.001-1.011, p = 0.027) were associated with higher incidence of radiation neuropathy. CONCLUSION: N classification remains the most significant survival predictor for NPC patients treated by SIB-IMRT after adjusting these biomarkers. GTV impacts not only on locoregional control but also radiation neuropathy.
引用
- Lin YH, Huang TL, Chien CY, et al. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy. Radiat Oncol. 2018. PMID: 29554940. doi:10.1186/s13014-018-0990-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。